SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-23-004531
Filing Date
2023-08-18
Accepted
2023-08-18 16:32:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 KINIKSA PHARMACEUTICALS, LTD. p23-2095sc13ga.htm SC 13G/A 60709
2 JOINT FILING AGREEMENT p23-2095exhibit99.htm EX-99.1 3385
  Complete submission text file 0000902664-23-004531.txt   65925
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90491 | Film No.: 231186256
SIC: 2834 Pharmaceutical Preparations

Mailing Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006
Business Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006 (345) 749-8643
HHLR ADVISORS, LTD. (Filed by) CIK: 0001762304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A